Skip to Main Content
October 3, 2025
Health Law Weekly

Featured Articles

Health Care Corporate Governance: Emerging Governance Topics Meriting Board Attention

Know Your Audit! Operational Considerations for Every Kind of Audit

Pfizer Reaches Drug Pricing Deal with Trump Administration

Current Topics

Antitrust

U.S. Court in California Allows Antitrust Claims Against Corcept to Proceed in Case Alleging Sham Litigation, Exclusive Dealing, and Kickbacks

Fraud and Compliance

Doctor Sentenced to Six Years in Prison for Massive Opioid Prescribing Scheme

Gilead Agrees to $3 Million Settlement of Kickback Allegations

Mail-Order Pharmacy Owner Agrees to Settle Kickback Allegations

Medical Device Company, Distributor Will Pay Nearly $37 Million to Resolve False Claims Act Allegations

Pharmacy Owner, Three Pharmacists Handed Prison Time for Illegal Opioid Conspiracy

Physician Indicted for Billing Medically Unnecessary Procedures

U.S. Court in Indiana Tosses Whistleblower Action Against Anthem Alleging Medicaid Fraud

Urgent Care Clinic Agrees to $2.8 Million Settlement of Fraud Allegations

Government Reimbursement

CMS Finalizes Guidance for Third Round of Medicare Drug Price Negotiations

Medicare Advantage Enrollment Projected to Decline in 2026

U.S. Court in DC Holds HHS Properly Excluded Psychiatric Residential Treatment Facility Days from Hospitals’ DSH Calculations

Health Information

Cadia Healthcare Facilities Pays $182,000 to Resolve Potential HIPAA Privacy, Breach Notification Rule Violations

Health Insurance

U.S. Court in Massachusetts Refuses to Block ACA Marketplace Integrity Rule

Health Law Policy and Administration Hub

FDA Approves Second Generic Abortion Pill

Funding Standoff Triggers First Government Shutdown in Nearly Seven Years

Trump Orders Expanding Use of AI to Advance Childhood Cancer Research

Life Sciences

U.S. Court Won’t Block Illinois Law Prohibiting Generic Drug “Price Gouging”

Current Issue
Health Law Weekly Issue - October 3, 2025